(Q44442596)

English

Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation

scientific article published on February 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Glycemic control in patients with type 2 diabetes mellitus switched from twice-daily immediate-release metformin to a once-daily extended-release formulation (English)

1 reference

Europe PubMed Central

3 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0149-2918(03)80093-0

https://api.crossref.org/works/10.1016/S0149-2918(03)80093-0

2 January 2024

author name string

Ken Fujioka

1

1 reference

Europe PubMed Central

3 December 2017

Miranda Pans

2

1 reference

Europe PubMed Central

3 December 2017

Steven Joyal

3

1 reference

Europe PubMed Central

3 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2003

1 reference

Europe PubMed Central

3 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0149291803800930?httpAccept=text/xml

1 reference

10.1016/S0149-2918(03)80093-0

https://api.crossref.org/works/10.1016/S0149-2918(03)80093-0

2 January 2024

https://api.elsevier.com/content/article/PII:S0149291803800930?httpAccept=text/plain

1 reference

10.1016/S0149-2918(03)80093-0

https://api.crossref.org/works/10.1016/S0149-2918(03)80093-0

2 January 2024

Clinical Therapeutics

1 reference

Europe PubMed Central

3 December 2017

25

1 reference

Europe PubMed Central

3 December 2017

2

1 reference

Europe PubMed Central

3 December 2017

515-529

1 reference

Europe PubMed Central

3 December 2017

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

National Pharmacy Cardiovascular Council treatment guidelines for the management of type 2 diabetes mellitus: toward better patient outcomes and new roles for pharmacists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Metformin in the digestive tract

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of prescribed daily dose frequency on patient medication compliance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

How often is medication taken as prescribed? A novel assessment technique

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980093-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food

11

1 reference

10.1016/S0149-2918(03)80093-0

https://api.crossref.org/works/10.1016/S0149-2918(03)80093-0

2 January 2024

Identifiers

10.1016/S0149-2918(03)80093-0

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44442596&oldid=2043719472"